{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:43:40Z","timestamp":1762868620541,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.oret.2021.07.008","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T19:42:38Z","timestamp":1632512558000},"page":"943-944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["OCT Alone to Diagnose and Manage Polypoidal Choroidal Vasculopathy"],"prefix":"10.1016","volume":"5","author":[{"given":"Peter K.","family":"Kaiser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2021.07.008_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0002-9394(85)90682-8","article-title":"Multiple recurrent serosanguineous retinal pigment epithelial detachments in Black women","volume":"100","author":"Stern","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2021.07.008_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00006982-199010010-00002","article-title":"The posterior uveal bleeding syndrome","volume":"10","author":"Kleiner","year":"1990","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.07.008_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3928\/1542-8877-19960601-12","article-title":"Indocyanine green angiography of idiopathic polypoidal choroidal vasculopathy","volume":"27","author":"Phillips","year":"1996","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.1016\/j.oret.2021.07.008_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","article-title":"Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy","volume":"15","author":"Spaide","year":"1995","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.07.008_bib5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting neovascular age-related macular degeneration data. Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2021.07.008_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.survophthal.2010.03.004","article-title":"Polypoidal choroidal vasculopathy: a review","volume":"55","author":"Imamura","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2021.07.008_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.survophthal.2003.10.007","article-title":"Polypoidal choroidal vasculopathy","volume":"49","author":"Ciardella","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2021.07.008_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s10384-020-00805-5","article-title":"Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy: 96-week outcomes in the Japanese subgroup of the PLANET study","volume":"65","author":"Ogura","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.oret.2021.07.008_bib9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1167\/iovs.17-22683","article-title":"EVEREST report 5: clinical outcomes and treatment response of polypoidal choroidal vasculopathy subtypes in a multicenter, randomized controlled trial","volume":"59","author":"Tan","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2021.07.008_bib10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamaophthalmol.2020.2443","article-title":"Comparison of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy","volume":"138","author":"Lim","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2021.07.008_bib11","first-page":"1857","article-title":"Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review","volume":"10","author":"Yang","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.oret.2021.07.008_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/IAE.0b013e318188c839","article-title":"A\u00a0Classification system for polypoidal choroidal vasculopathy","volume":"29","author":"Cackett","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.07.008_bib13","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s00417-013-2336-1","article-title":"Changes in fundus autofluorescence in polypoidal choroidal vasculopathy during 3 years of follow-up","volume":"251","author":"Suzuki","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2021.07.008_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/01.APO.0000656992.00746.48","article-title":"Latest developments in polypoidal choroidal vasculopathy: epidemiology, etiology, diagnosis, and treatment","volume":"9","author":"Chaikitmongkol","year":"2020","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.oret.2021.07.008_bib15","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.oret.2021.04.002","article-title":"Non-ICGA treatment criteria for suboptimal anti-VEGF response for polypoidal choroidal vasculopathy: APOIS PCV Workgroup report 2","volume":"5","author":"Teo","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2021.07.008_bib16","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1097\/IAE.0b013e318285cbb3","article-title":"Optical coherence tomographic enhanced depth imaging of polypoidal choroidal vasculopathy","volume":"33","author":"Yang","year":"2013","journal-title":"Retina (Phila)"},{"key":"10.1016\/j.oret.2021.07.008_bib17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3928\/1542-8877-20000501-09","article-title":"Optical coherence tomographic findings of idiopathic polypoidal choroidal vasculopathy","volume":"31","author":"Otsuji","year":"2000","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.1016\/j.oret.2021.07.008_bib18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.preteyeres.2005.01.001","article-title":"Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm","volume":"24","author":"Costa","year":"2005","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oret.2021.07.008_bib19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/IAE.0b013e3182852446","article-title":"Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment","volume":"33","author":"Koh","year":"2013","journal-title":"Retina (Phila)"},{"key":"10.1016\/j.oret.2021.07.008_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","article-title":"Polypoidal choroidal vasculopathy: consensus nomenclature and non-indocyanine green angiograph diagnostic criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup","volume":"128","author":"Cheung","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2021.07.008_bib21","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.oret.2021.05.009","article-title":"Differentiating exudative macular degeneration and polypoidal choroidal vasculopathy using optical coherence tomography B-scan","volume":"5","author":"Kokame","year":"2021","journal-title":"Ophthalmol Retina"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653021002372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653021002372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:29:54Z","timestamp":1762853394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653021002372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2468653021002372"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2021.07.008","relation":{},"ISSN":["2468-6530"],"issn-type":[{"type":"print","value":"2468-6530"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OCT Alone to Diagnose and Manage Polypoidal Choroidal Vasculopathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2021.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2021.04.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}